Related references
Note: Only part of the references are listed.Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin
Mi Jin Yoon et al.
CARCINOGENESIS (2012)
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2012)
Resistance to TRAIL and how to surmount it
Danijela Maksimovic-Ivanic et al.
IMMUNOLOGIC RESEARCH (2012)
The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer
Zhongmei Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition
Xiaoyan Li et al.
CANCER SCIENCE (2011)
Metadherin as a link between metastasis and chemoresistance
Yong Wei et al.
CELL CYCLE (2011)
Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses
Claudia Bossen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Significance of AEG-1 Expression in Correlation With VEGF, Microvessel Density and Clinicopathological Characteristics in Triple-Negative Breast Cancer
Cong Li et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Identification of Novel Variants of Metadherin in Breast Cancer
Xianqiang Liu et al.
PLOS ONE (2011)
Activation of the Akt Survival Pathway Contributes to TRAIL Resistance in Cancer Cells
Jing Xu et al.
PLOS ONE (2010)
CK2 beta Is Expressed in Endometrial Carcinoma and Has a Role in Apoptosis Resistance and Cell Proliferation
Judit Pallares et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Is TRAIL the holy grail of cancer therapy?
Thomas Newsom-Davis et al.
APOPTOSIS (2009)
TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype
Monzur Rahman et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer
Guohong Hu et al.
CANCER CELL (2009)
TRAIL receptor signalling and modulation: Are we on the right TRAIL?
Devalingam Mahalingam et al.
CANCER TREATMENT REVIEWS (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
The Multifaceted Role of MTDH/AEG-1 in Cancer Progression
Guohong Hu et al.
CLINICAL CANCER RESEARCH (2009)
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression
Byoung Kwon Yoo et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice
Sharmila Shankar et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma
S-G Lee et al.
ONCOGENE (2009)
Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1
J. Li et al.
ONCOGENE (2009)
Identification of genes conferring resistance to 5-fluorouracil
Byoung Kwon Yoo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival
Jun Li et al.
CLINICAL CANCER RESEARCH (2008)
Aspirin sensitizes cancer cells to TRAIL-Induced apoptosis by reducing survivin levels
Meiling Lu et al.
CLINICAL CANCER RESEARCH (2008)
The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2 and EGFR through RING finger protein 11
C. Chen et al.
ONCOGENE (2008)
Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling
S-G Lee et al.
ONCOGENE (2008)
被撤回的出版物: Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity (Retracted article. See vol. 41, pg. 4981, 2022)
N. Kikuno et al.
ONCOGENE (2007)
Direct and sensitive miRNA profiling from low-input total RNA
Hui Wang et al.
RNA (2007)
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
LD Zhang et al.
CANCER GENE THERAPY (2005)
A genotyping system capable of simultaneously analyzing >1000 single nucleotide polymorphisms in a haploid genome
HY Wang et al.
GENOME RESEARCH (2005)
Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP
EH Kim et al.
ONCOGENE (2004)
Death induction by recombinant native TRAIL and its prevention by a caspase 9 inhibitor in primary human Esophageal epithelial cells
SH Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression
S Fulda et al.
ONCOGENE (2002)
High-speed digital microscopy
MJ Sanderson
METHODS-A COMPANION TO METHODS IN ENZYMOLOGY (2000)
Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistance to a series of anticancer drugs in breast carcinoma
QF Yang et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
Share Paper
